In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome.
Chávez-Gutiérrez E, Martínez-Arellanes M, Murillo-López M, Medina-Guzmán MF, Mobarak-Richaud L, Pelcastre-Guzmán K, Quintana-Romero OJ, Ariza-Castolo A, Ayala-Moreno MDR, Salazar JR, Guerra-Araiza C, Rodríguez-Páez L, Pinto-Almazán R, Loza-Mejía MA.
Chávez-Gutiérrez E, et al. Among authors: guerra araiza c.
Pharmaceuticals (Basel). 2022 Nov 25;15(12):1461. doi: 10.3390/ph15121461.
Pharmaceuticals (Basel). 2022.
PMID: 36558912
Free PMC article.